Delivery Order SPE2DR25D1106-SPE2DR26FJB2S
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,498.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Aprepitant 40 mg capsules in unit dose packages of five (4570102395). The contract, valued at $4,672.30, is set to be completed by November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $7,480.03 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packages of five. The contract, awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, utilizes firm fixed price pricing with no set-aside designation. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $11,086.37 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit dose packaging (six-count). This order was competitively awarded without set-aside designation and carries a firm fixed price contract type, with an ultimate completion date of November 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Aprepitant 80 mg capsule unit dose packages in quantities of six, with a contract ceiling value of $10,700.65. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the order is scheduled for completion...
- The Defense Logistics Agency awarded a delivery order valued at $9,618.63 to AmerisourceBergen Drug Corp for the supply of Aprepitant 80 mg capsules in unit-dose packaging. The contract, executed on November 10, 2025, with an ultimate completion date of November 12, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in...
- The Defense Logistics Agency awarded a $59,503.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for Aprepitant 40 mg capsule unit dose packets in quantities of five. The contract, which represents a non-set-aside competitive award, is performance-based through December 4, 2025, with fulfillment occurring at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.19 to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging of 5s. This competitive award, executed on April 23, 2025, with an ultimate completion date of April 24, 2025, reflects a firm fixed-price contract type with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJB2SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 40 mg capsules in unit dose packaging (5s) with a ceiling value of $30,197.23. This firm fixed price delivery order, awarded on November 26, 2025, with an ultimate completion date of November 28, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, supplying a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive contract history with the DLA demonstrates its capability to meet federal procurement requirements for essential pharmaceutical commodities supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.2k | 11/25/25 |